Edition:
United Kingdom

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,722JPY
4:41am BST
Change (% chg)

¥61 (+1.31%)
Prev Close
¥4,661
Open
¥4,700
Day's High
¥4,729
Day's Low
¥4,686
Volume
4,325,300
Avg. Vol
4,413,652
52-wk High
¥6,693
52-wk Low
¥4,203

Select another date:

Fri, Sep 28 2018

Photo

Takeda's $62 billion Shire bid faces November 6 EU antitrust deadline

BRUSSELS EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's $62-billion takeover of London-listed Shire Plc , the European Commission said on Friday.

Takeda's $62 billion Shire bid faces Nov. 6 EU antitrust deadline

BRUSSELS EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's $62-billion (47.5 billion pounds) takeover of London-listed Shire Plc , the European Commission said on Friday.

Takeda's $62 bln Shire bid faces Nov. 6 EU antitrust deadline

BRUSSELS, Sept 28 EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's $62-billion takeover of London-listed Shire Plc, the European Commission said on Friday.

Takeda lung cancer drug gets European panel nod

Sept 21 Takeda Pharmaceutical Co's lung cancer drug received the recommendation of a European Union panel on Friday, more than a year after it won regulatory approval to be sold in the United States.

Takeda gets China's approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the Japanese group closer to becoming a global top 10 drugmaker.

Takeda gets China's approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc , the latest regulator to clear the $62 billion (47 billion pounds) deal and bring the Japanese group closer to becoming a global top 10 drugmaker.

UPDATE 1-Takeda gets China's approval for $62 bln Shire purchase

* Takeda still awaiting approval from EU, Japan (Adds background, share price)

Takeda gets China's approval for $62 bln Shire purchase

Sept 14 Japan's Takeda Pharmaceutical Co Ltd said on Friday China's market regulator had approved its $62 billion acquisition of Shire Plc, bringing it closer to becoming a global top 10 drugmaker.

Takeda weighs sale of Shire's eye care business to cut debt: Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday.

Takeda weighs sale of Shire's eye care business to cut debt - Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion (47 billion pounds) purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday.

Select another date: